<p>汤普森·戴维斯公司在第二季度收购了 CVS Health Corporation（纽约证券交易所代码：CVS - 免费报告）的新股份，根据其最近向证券交易委员会（SEC）提交的 13F 表格。该机构投资者收购了 16,529 股该药房运营商的股票，价值约为 1,140,000 美元。</p>
<ul>
<li>CVS Health 因收入增长而上涨，股息保持强劲</li>
</ul>
<p>其他几家对冲基金和机构投资者也调整了对 CVS 的持股。FineMark 国家银行和信托在第二季度将其在 CVS Health 的持股增加了 1.7%。FineMark 国家银行和信托目前拥有 9,576 股该药房运营商的股票，价值 661,000 美元，在此期间又收购了 157 股。Smartleaf 资产管理公司在第二季度将其在 CVS Health 的股份增加了 1.1%。Smartleaf 资产管理公司目前拥有 15,059 股该药房运营商的股票，价值 1,031,000 美元，在上个季度又购买了 164 股。Hazlett Burt &amp; Watson 公司在第二季度将其在 CVS Health 的股份增加了 10.9%。Hazlett Burt &amp; Watson 公司目前拥有 1,682 股该药房运营商的股票，价值 117,000 美元，在此期间又购买了 165 股。Loomis Sayles &amp; Co. L P 在第二季度将其在 CVS Health 的持股增加了 11.0%。Loomis Sayles &amp; Co. L P 目前拥有 1,674 股该药房运营商的股票，价值 115,000 美元，在上个季度又购买了 166 股。最后，Williams Financial LLC 在第二季度将其在 CVS Health 的股份增加了 2.5%。Williams Financial LLC 目前拥有 6,923 股该药房运营商的股票，价值 478,000 美元，在此期间又购买了 167 股。机构投资者持有该公司 80.66% 的股份。</p>
<h2>CVS Health 股票表现</h2>
<p>CVS Health 的股票在周五开盘价为 79.45 美元。该公司的流动比率为 0.83，速动比率为 0.63，债务与股本比率为 0.83。该公司的市值为 1,008.5 亿美元，市盈率为 209.08，市盈率增长比率为 0.78，贝塔值为 0.48。该公司的 50 日移动平均线为 78.97 美元，200 日移动平均线为 71.91 美元。CVS Health Corporation 的 1 年最低价为 43.56 美元，1 年最高价为 85.15 美元。</p>
<ul>
<li>MarketBeat 周回顾 – 05/12 - 05/16</li>
</ul>
<p>CVS Health（纽约证券交易所代码：CVS - 获取免费报告）最近于 10 月 29 日（星期三）公布了季度财报。该药房运营商报告每股收益（EPS）为 1.60 美元，超出分析师一致预期的 1.36 美元，超出幅度为 0.24 美元。CVS Health 的净利润率为 0.12%，股本回报率为 11.45%。该公司本季度的收入为 1,028.7 亿美元，而分析师预期为 988.5 亿美元。去年同期，该公司每股收益为 1.09 美元。该公司的季度收入同比增长 7.8%。CVS Health 已将其 2025 财年的指导目标设定为 6.550-6.650 EPS。作为一个整体，股票研究分析师预测 CVS Health Corporation 在当前财年将发布 5.89 的每股收益。</p>
<h2>CVS Health 股息公告</h2>
<p>该公司最近还披露了季度股息，该股息于 11 月 3 日（星期一）支付。10 月 23 日（星期四）的登记投资者获得了 0.665 美元的股息。该股息的除息日期为 10 月 23 日（星期四）。这代表着每年 2.66 美元的股息和 3.3% 的收益率。CVS Health 的股息支付比率（DPR）为 700.00%。</p>
<h2>华尔街分析师观点</h2>
<ul>
<li>现在是购买 Novo Nordisk 股票的时机吗？</li>
</ul>
<p>一些股票研究分析师最近对该公司发表了看法。桑福德·C·伯恩斯坦在周五将 CVS Health 的目标价从 86.00 美元上调至 87.00 美元，并给予该股票 “市场表现” 评级。瑞银集团在周三重申了对 CVS Health 股票的 “跑赢大盘” 评级。瑞穗证券在周三将 CVS Health 股票的目标价从 88.00 美元上调至 95.00 美元，并给予该公司 “跑赢大盘” 评级。摩根士丹利在周三将 CVS Health 股票的目标价从 89.00 美元上调至 93.00 美元，并给予该股票 “增持” 评级。最后，Leerink Partners 在 10 月 16 日（星期四）将 CVS Health 的目标价从 86.00 美元上调至 95.00 美元，并给予该公司 “跑赢大盘” 评级。两位分析师对该股票给予了强烈买入评级，二十位分析师给予了买入评级，四位分析师对该公司给予了持有评级。根据 MarketBeat 的数据，该公司目前的平均评级为 “适度买入”，共识目标价为 93.71 美元。</p>
<p><strong>查看我们关于 CVS 的最新研究报告</strong></p>
<h2>CVS Health 公司简介</h2>
<p>（免费报告）</p>
<p>CVS Health Corporation 在美国提供健康解决方案。它通过医疗保险、健康服务和药房及消费者健康三个部门运营。医疗保险部门提供传统、自愿和消费者导向的健康保险产品及相关服务。</p>
<h2>另请参阅</h2>
<ul>
<li>我们更看好的五只股票超过 CVS Health</li>
<li>除息日对投资者的重要性是什么？</li>
<li>迪士尼的 10 亿美元交易将其魔力带入 OpenAI</li>
<li>投资石油股票的方式和原因</li>
<li>为什么亚马逊可能在几周内成为 300 美元的股票</li>
<li>什么是股息？购买最佳股息股票</li>
<li>Adobe 在财报后获得提振：长期前景看涨</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNWUw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNWUw"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 CVS Health 吗？</h2>
<p>在考虑 CVS Health 之前，你会想听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已经识别出五只顶级分析师正在悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 CVS Health 并不在名单上。</p>
<p>虽然 CVS Health 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

西维斯

<p>Thompson Davis & CO. Inc. 在第二季度投资了 114 万美元于 CVS Health Corporation，购买了 16,529 股。其他机构投资者也调整了他们的持股。CVS Health 报告了强劲的季度收益，超出预期，每股收益为 1.60 美元，收入为 1028.7 亿美元。分析师提高了目标价格，评级范围从 “市场表现” 到 “跑赢大盘”。CVS Health 的股息收益率为 3.3%，派息比率为 700%。机构投资者持有 CVS 股票的 80.66%</p>

<p>Thompson Davis &amp; CO. Inc. acquired a new stake in CVS Health Corporation (NYSE:CVS - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 16,529 shares of the pharmacy operator's stock, valued at approximately $1,140,000.</p>
<div class="lb-trans"><p>汤普森·戴维斯公司在第二季度收购了 CVS Health Corporation（纽约证券交易所代码：CVS - 免费报告）的新股份，根据其最近向证券交易委员会（SEC）提交的 13F 表格。该机构投资者收购了 16,529 股该药房运营商的股票，价值约为 1,140,000 美元。</p>
</div><ul>
<li>CVS Health Gains as Revenue Grows, Dividend Remains Strong</li>
</ul>
<div class="lb-trans"><ul>
<li>CVS Health 因收入增长而上涨，股息保持强劲</li>
</ul>
</div><p>Several other hedge funds and other institutional investors have also modified their holdings of CVS. FineMark National Bank &amp; Trust raised its holdings in CVS Health by 1.7% in the 2nd quarter. FineMark National Bank &amp; Trust now owns 9,576 shares of the pharmacy operator's stock valued at $661,000 after acquiring an additional 157 shares during the period. Smartleaf Asset Management LLC grew its position in shares of CVS Health by 1.1% in the second quarter. Smartleaf Asset Management LLC now owns 15,059 shares of the pharmacy operator's stock valued at $1,031,000 after purchasing an additional 164 shares during the last quarter. Hazlett Burt &amp; Watson Inc. increased its stake in shares of CVS Health by 10.9% during the second quarter. Hazlett Burt &amp; Watson Inc. now owns 1,682 shares of the pharmacy operator's stock worth $117,000 after purchasing an additional 165 shares during the period. Loomis Sayles &amp; Co. L P lifted its holdings in CVS Health by 11.0% during the 2nd quarter. Loomis Sayles &amp; Co. L P now owns 1,674 shares of the pharmacy operator's stock worth $115,000 after purchasing an additional 166 shares during the last quarter. Finally, Williams Financial LLC boosted its stake in CVS Health by 2.5% in the 2nd quarter. Williams Financial LLC now owns 6,923 shares of the pharmacy operator's stock valued at $478,000 after purchasing an additional 167 shares during the period. Institutional investors own 80.66% of the company's stock.</p>
<div class="lb-trans"><p>其他几家对冲基金和机构投资者也调整了对 CVS 的持股。FineMark 国家银行和信托在第二季度将其在 CVS Health 的持股增加了 1.7%。FineMark 国家银行和信托目前拥有 9,576 股该药房运营商的股票，价值 661,000 美元，在此期间又收购了 157 股。Smartleaf 资产管理公司在第二季度将其在 CVS Health 的股份增加了 1.1%。Smartleaf 资产管理公司目前拥有 15,059 股该药房运营商的股票，价值 1,031,000 美元，在上个季度又购买了 164 股。Hazlett Burt &amp; Watson 公司在第二季度将其在 CVS Health 的股份增加了 10.9%。Hazlett Burt &amp; Watson 公司目前拥有 1,682 股该药房运营商的股票，价值 117,000 美元，在此期间又购买了 165 股。Loomis Sayles &amp; Co. L P 在第二季度将其在 CVS Health 的持股增加了 11.0%。Loomis Sayles &amp; Co. L P 目前拥有 1,674 股该药房运营商的股票，价值 115,000 美元，在上个季度又购买了 166 股。最后，Williams Financial LLC 在第二季度将其在 CVS Health 的股份增加了 2.5%。Williams Financial LLC 目前拥有 6,923 股该药房运营商的股票，价值 478,000 美元，在此期间又购买了 167 股。机构投资者持有该公司 80.66% 的股份。</p>
</div><h2>CVS Health Stock Performance</h2>
<div class="lb-trans"><h2>CVS Health 股票表现</h2>
</div><p>Shares of CVS Health stock opened at $79.45 on Friday. The company has a current ratio of 0.83, a quick ratio of 0.63 and a debt-to-equity ratio of 0.83. The company has a market cap of $100.85 billion, a PE ratio of 209.08, a price-to-earnings-growth ratio of 0.78 and a beta of 0.48. The company has a 50 day moving average of $78.97 and a 200-day moving average of $71.91. CVS Health Corporation has a 1-year low of $43.56 and a 1-year high of $85.15.</p>
<div class="lb-trans"><p>CVS Health 的股票在周五开盘价为 79.45 美元。该公司的流动比率为 0.83，速动比率为 0.63，债务与股本比率为 0.83。该公司的市值为 1,008.5 亿美元，市盈率为 209.08，市盈率增长比率为 0.78，贝塔值为 0.48。该公司的 50 日移动平均线为 78.97 美元，200 日移动平均线为 71.91 美元。CVS Health Corporation 的 1 年最低价为 43.56 美元，1 年最高价为 85.15 美元。</p>
</div><ul>
<li>MarketBeat Week in Review – 05/12 - 05/16</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周回顾 – 05/12 - 05/16</li>
</ul>
</div><p>CVS Health (NYSE:CVS - Get Free Report) last announced its quarterly earnings data on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.36 by $0.24. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The business had revenue of $102.87 billion for the quarter, compared to analysts' expectations of $98.85 billion. During the same period last year, the firm posted $1.09 earnings per share. The firm's quarterly revenue was up 7.8% compared to the same quarter last year. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. As a group, equities research analysts forecast that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>CVS Health（纽约证券交易所代码：CVS - 获取免费报告）最近于 10 月 29 日（星期三）公布了季度财报。该药房运营商报告每股收益（EPS）为 1.60 美元，超出分析师一致预期的 1.36 美元，超出幅度为 0.24 美元。CVS Health 的净利润率为 0.12%，股本回报率为 11.45%。该公司本季度的收入为 1,028.7 亿美元，而分析师预期为 988.5 亿美元。去年同期，该公司每股收益为 1.09 美元。该公司的季度收入同比增长 7.8%。CVS Health 已将其 2025 财年的指导目标设定为 6.550-6.650 EPS。作为一个整体，股票研究分析师预测 CVS Health Corporation 在当前财年将发布 5.89 的每股收益。</p>
</div><h2>CVS Health Dividend Announcement</h2>
<div class="lb-trans"><h2>CVS Health 股息公告</h2>
</div><p>The firm also recently disclosed a quarterly dividend, which was paid on Monday, November 3rd. Investors of record on Thursday, October 23rd were paid a $0.665 dividend. The ex-dividend date of this dividend was Thursday, October 23rd. This represents a $2.66 annualized dividend and a yield of 3.3%. CVS Health's dividend payout ratio (DPR) is 700.00%.</p>
<div class="lb-trans"><p>该公司最近还披露了季度股息，该股息于 11 月 3 日（星期一）支付。10 月 23 日（星期四）的登记投资者获得了 0.665 美元的股息。该股息的除息日期为 10 月 23 日（星期四）。这代表着每年 2.66 美元的股息和 3.3% 的收益率。CVS Health 的股息支付比率（DPR）为 700.00%。</p>
</div><h2>Wall Street Analyst Weigh In</h2>
<div class="lb-trans"><h2>华尔街分析师观点</h2>
</div><ul>
<li>Is It Time to Buy the Dip in Novo Nordisk Stock?</li>
</ul>
<div class="lb-trans"><ul>
<li>现在是购买 Novo Nordisk 股票的时机吗？</li>
</ul>
</div><p>A number of equities research analysts have recently weighed in on the company. Sanford C. Bernstein lifted their target price on CVS Health from $86.00 to $87.00 and gave the stock a &#34;market perform&#34; rating in a report on Friday. UBS Group reiterated an &#34;outperform&#34; rating on shares of CVS Health in a research note on Wednesday. Mizuho boosted their price objective on shares of CVS Health from $88.00 to $95.00 and gave the company an &#34;outperform&#34; rating in a report on Wednesday. Morgan Stanley raised their target price on shares of CVS Health from $89.00 to $93.00 and gave the stock an &#34;overweight&#34; rating in a report on Wednesday. Finally, Leerink Partners boosted their price target on CVS Health from $86.00 to $95.00 and gave the company an &#34;outperform&#34; rating in a research note on Thursday, October 16th. Two analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat, the company currently has an average rating of &#34;Moderate Buy&#34; and a consensus target price of $93.71.</p>
<div class="lb-trans"><p>一些股票研究分析师最近对该公司发表了看法。桑福德·C·伯恩斯坦在周五将 CVS Health 的目标价从 86.00 美元上调至 87.00 美元，并给予该股票 “市场表现” 评级。瑞银集团在周三重申了对 CVS Health 股票的 “跑赢大盘” 评级。瑞穗证券在周三将 CVS Health 股票的目标价从 88.00 美元上调至 95.00 美元，并给予该公司 “跑赢大盘” 评级。摩根士丹利在周三将 CVS Health 股票的目标价从 89.00 美元上调至 93.00 美元，并给予该股票 “增持” 评级。最后，Leerink Partners 在 10 月 16 日（星期四）将 CVS Health 的目标价从 86.00 美元上调至 95.00 美元，并给予该公司 “跑赢大盘” 评级。两位分析师对该股票给予了强烈买入评级，二十位分析师给予了买入评级，四位分析师对该公司给予了持有评级。根据 MarketBeat 的数据，该公司目前的平均评级为 “适度买入”，共识目标价为 93.71 美元。</p>
</div><p><strong>Check Out Our Latest Research Report on CVS</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 CVS 的最新研究报告</strong></p>
</div><h2>CVS Health Company Profile</h2>
<div class="lb-trans"><h2>CVS Health 公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy &amp; Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.</p>
<div class="lb-trans"><p>CVS Health Corporation 在美国提供健康解决方案。它通过医疗保险、健康服务和药房及消费者健康三个部门运营。医疗保险部门提供传统、自愿和消费者导向的健康保险产品及相关服务。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另请参阅</h2>
</div><ul>
<li>Five stocks we like better than CVS Health</li>
<li>Why is the Ex-Dividend Date Significant to Investors?</li>
<li>Disney's $1 Billion Deal Brings Its Magic to OpenAI</li>
<li>The How And Why of Investing in Oil Stocks</li>
<li>Why Amazon Could Be a $300 Stock Within Weeks</li>
<li>What Are Dividends? Buy the Best Dividend Stocks</li>
<li>Adobe Gets Post-Earnings Lift: Long-Term Outlook Favors Upside</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票超过 CVS Health</li>
<li>除息日对投资者的重要性是什么？</li>
<li>迪士尼的 10 亿美元交易将其魔力带入 OpenAI</li>
<li>投资石油股票的方式和原因</li>
<li>为什么亚马逊可能在几周内成为 300 美元的股票</li>
<li>什么是股息？购买最佳股息股票</li>
<li>Adobe 在财报后获得提振：长期前景看涨</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNWUw" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=CVS"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in CVS Health Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 CVS Health 吗？</h2>
</div><p>Before you consider CVS Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 CVS Health 之前，你会想听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已经识别出五只顶级分析师正在悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 CVS Health 并不在名单上。</p>
</div><p>While CVS Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 CVS Health 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Thompson Davis & CO. Inc. 对 CVS Health Corporation（西维斯公司）进行了新的 114 万美元投资